IAVI

IAVI is a nonprofit scientific research organization with offices and labs in Africa, India, Europe, and the U.S. Their primary focus is on developing vaccines and antibodies for HIV, tuberculosis, and emerging infectious diseases. The organization conducts clinical research to fulfill its mission of creating a safe and affordable globally accessible HIV vaccine while also working on other HIV prevention methods, tuberculosis vaccines, and addressing the limitations of existing vaccines for emerging infectious diseases. IAVI's work aims to alleviate the heavy personal and financial toll these diseases exact, particularly on those living in poverty.

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This news site is known for its high journalistic standards. It strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. It has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

  • Seventh Person May Have Been Cured of HIV After Stem Cell Transplant: Lessons for Future Research

    Seventh Person May Have Been Cured of HIV After Stem Cell Transplant: Lessons for Future Research

    Broke On: Tuesday, 23 July 2024 A potential seventh person may have been cured of HIV after receiving a stem cell transplant for leukemia at the International AIDS Conference in Munich. The German man, who received the transplant in 2015 and stopped taking antiretroviral drugs in 2018, has since tested negative for viable HIV. This medical milestone adds to the growing body of evidence that a cure for HIV is possible through stem cell transplants, despite the complexities and challenges involved.